Aug 3, 2026

Our Director, Dr. Ethel Feleder, speaker at SAFYBI's Bioequivalence course

Dr. Ethel Feleder is among the speakers of the course "Updates on Bioequivalence Studies" organized by SAFYBI, from August 5 to 26, 2026.

SAFYBI - Updates on Bioequivalence Studies, August 5, 2026

SAFYBI (Sociedad Argentina de Farmacia y Bioquímica Industrial) is organizing the course “Updates on Bioequivalence Studies”, to be held on August 5, 12, 19 and 26, 2026, from 6:00 to 9:00 PM, in synchronous online format, with a total of 12 hours and a certificate with evaluation.

The course offers an updated, critical view of bioequivalence studies for the development of generic and multisource medicines in Argentina and LATAM: current regulations, biowaivers, the latest international trends, virtual bioequivalence, and the new FDA guidelines.

We are proud that our Director, Dr. Ethel Feleder, is among the speakers, alongside Dr. Carolina Sian (Course Director), Dr. Sofía Helena Harriet, Dr. Fernando Costa, and Dr. María Sylvia Viola (Coordinator).

SAFYBI members receive a 50% discount on registration.

More information and registration (SAFYBI)

Related news

Aug 3, 2026

Our Director, Dr. Ethel Feleder, speaker at SAFYBI's Bioequivalence course

Read more
Jan 21, 2026

ANMAT regulatory update – Bioequivalence/Bioavailability

Read more